Search

Displaying results 3501 - 3510 of 10000 in total
  1. Drug

    Amilomotide

    go.drugbank.com/drugs/DB05150
    Investigational

    CAD106 is an immunotherapeutic product in development for the treatment of Alzheimer's disease. … It is designed to induce antibodies against the beta-amyloid-protein that inhibit the formation of plaques in the brain of Alzheimer's disease patients.

  2. Drug

    Calendula officinalis flower

    go.drugbank.com/drugs/DB14263
    Approved

    Calendula officinalis flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    Rumex crispus whole

    go.drugbank.com/drugs/DB14267
    Approved

    Rumex crispus whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Ocimum tenuiflorum top

    go.drugbank.com/drugs/DB14273
    ApprovedWithdrawn

    Ocimum tenuiflorum top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  5. Drug

    Angelica archangelica root

    go.drugbank.com/drugs/DB14283
    Approved

    Angelica archangelica root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Kaempferia galanga root

    go.drugbank.com/drugs/DB14288
    ApprovedWithdrawn

    Kaempferia galanga root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    Inula helenium root

    go.drugbank.com/drugs/DB14350
    Approved

    Inula helenium root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  8. Drug

    MK-4721

    go.drugbank.com/drugs/DB05933
    Investigational

    MK-4721 is a fully human monoclonal antibody directed to Agensys’ proprietary target Prostate Stem Cell Antigen (PSCA), an antigen expressed at significant levels on tumor cells from the majority of patients

  9. Drug

    ICA-105665

    go.drugbank.com/drugs/DB06089
    Investigational

    In addition, ICA-105665 has also demonstrated activity in certain models of neuropathic pain. … It is a novel opener of the KCNQ ion channel which in preclinical studies has demonstrated a broad spectrum of activity in models of epilepsy.

  10. Drug

    EHT899

    go.drugbank.com/drugs/DB05108
    Experimental

    It also apparently enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load. … EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection.